PERSISTENT VULVAR CANCER

Clinical trials for PERSISTENT VULVAR CANCER explained in plain language.

Never miss a new study

Get alerted when new PERSISTENT VULVAR CANCER trials appear

Sign up with your email to follow new studies for PERSISTENT VULVAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat vulvar cancer

Disease control Recruiting now

This study is testing whether a combination of two existing cancer drugs, pembrolizumab and lenvatinib, can help control advanced vulvar cancer that has returned or spread and cannot be treated with surgery or radiation. It will enroll about 42 patients to see if the combination …

Matched conditions: PERSISTENT VULVAR CANCER

Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

PERSISTENT VULVAR CANCER

Get alerted when new PERSISTENT VULVAR CANCER trials appear

New hope for Tough-to-Treat vulvar cancer